Average Co-Inventor Count = 7.51
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alectos Therapeutics Inc. (7 from 18 patents)
2. Merck Sharp + Dohme Corp. (5 from 2,405 patents)
3. Zalicus Pharmaceuticals, Ltd. (4 from 8 patents)
4. Praxis Precision Medicines, Inc. (28 patents)
5. Taro Pharmaceuticals Inc. (4 patents)
11 patents:
1. 10081601 - Glucocerebrosidase modulators and uses thereof
2. 9938299 - Glycosidase inhibitors and uses thereof
3. 9815861 - Selective glycosidase inhibitors and uses thereof
4. 9796680 - Glucocerebrosidase modulators and uses thereof
5. 9718854 - Selective glycosidase inhibitors and uses thereof
6. 9695197 - Glycosidase inhibitors and uses thereof
7. 9243020 - Selective glycosidase inhibitors and uses thereof
8. 9096522 - N-piperidinyl acetamide derivatives as calcium channel blockers
9. 8569344 - N-piperidinyl acetamide derivatives as calcium channel blockers
10. 8377968 - N-piperidinyl acetamide derivatives as calcium channel blockers
11. 8133998 - Bicyclic pyrimidine derivatives as calcium channel blockers